Acer therapeutics to participate in h.c. wainwright 23rd annual global investment conference

Newton, mass., aug. 30, 2021 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that acer's management team will present and host one-on-one investor meetings at the upcoming h.c. wainwright global investment conference september 13-15, 2021.
ACER Ratings Summary
ACER Quant Ranking